The potential reclassification of cannabinoids, particularly at the federal level, is generating considerable buzz within the industry. A shift away from Schedule I status, often regarded as outdated and hindering https://bookmarks-hit.com/story23860345/cannabinoid-rescheduling-a-growth-catalyst